Title: William Baker: Innovator in Respiratory Treatment
Introduction
William Baker is an accomplished inventor based in the United States. He has made significant contributions to the field of respiratory treatments, particularly through his innovative formulations. His work focuses on the combination of antibiotics for effective treatment against bacterial respiratory infections.
Latest Patents
William Baker holds a notable patent titled "Aerosolized Fosfomycin/Aminoglycoside Combination For The Treatment Of Bacterial Respiratory Infections." This patent describes a formulation that combines fosfomycin and tobramycin for delivery via aerosolization. The concentrated formulation is designed to inhibit susceptible bacteria effectively. The dual ampoule system allows for separate formulation of fosfomycin and tobramycin, ensuring that when reconstituted, the pH remains between 4.5 and 8.0. This method of treatment is particularly effective for respiratory tract infections, utilizing aerosol delivery with a mass median aerodynamic diameter predominantly between 1 to 5 µ, produced by a jet or ultrasonic nebulizer or dry powder inhaler.
Career Highlights
William Baker is associated with Corus Pharma, Inc., where he continues to develop innovative solutions for respiratory health. His work has been instrumental in advancing treatment options for patients suffering from bacterial infections.
Collaborations
William collaborates with David Macleod, contributing to the development of effective respiratory treatments. Their partnership enhances the research and innovation process within the company.
Conclusion
William Baker is a key figure in the field of respiratory treatment innovations. His work on aerosolized antibiotic combinations represents a significant advancement in medical technology. His contributions continue to impact the treatment of bacterial respiratory infections positively.